Dewpoint Therapeutics closed Series D to advance first-in-class condensate modulator into clinical development for gastric cancer.
Dewpoint Therapeutics is a biotechnology company focused on drug discovery through the study of biomolecular condensates
Dewpoint Therapeutics is a biotechnology company focused on drug discovery through the study of biomolecular condensates. They utilize an integrated platform that combines biology, chemistry, and AI to develop new therapies targeting complex diseases.